Middle East Healthcare Company

SASE:4009 Rapporto sulle azioni

Cap. di mercato: ر.س6.9b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Middle East Healthcare Dividendo

Dividendo criteri di controllo 0/6

Middle East Healthcare al momento non paga dividendi.

Informazioni chiave

0%

Rendimento del dividendo

0%

Rapporto di remunerazione

Rendimento medio del settore1.4%
Prossima data di pagamento dei dividendin/a
Data di stacco del dividendon/a
Dividendo per azioneر.س2.000
Utile per azioneر.س2.20
Previsione del rendimento del dividendo a 3 anni1.3%

Aggiornamenti recenti sui dividendi

Nessun aggiornamento

Recent updates

Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 09
Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Middle East Healthcare Company's (TADAWUL:4009) Price In Tune With Earnings

Jul 18
Middle East Healthcare Company's (TADAWUL:4009) Price In Tune With Earnings

There's Been No Shortage Of Growth Recently For Middle East Healthcare's (TADAWUL:4009) Returns On Capital

May 30
There's Been No Shortage Of Growth Recently For Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 09
Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

If EPS Growth Is Important To You, Middle East Healthcare (TADAWUL:4009) Presents An Opportunity

Apr 29
If EPS Growth Is Important To You, Middle East Healthcare (TADAWUL:4009) Presents An Opportunity

Why Investors Shouldn't Be Surprised By Middle East Healthcare Company's (TADAWUL:4009) 27% Share Price Plunge

Apr 02
Why Investors Shouldn't Be Surprised By Middle East Healthcare Company's (TADAWUL:4009) 27% Share Price Plunge

There's Reason For Concern Over Middle East Healthcare Company's (TADAWUL:4009) Massive 40% Price Jump

Feb 11
There's Reason For Concern Over Middle East Healthcare Company's (TADAWUL:4009) Massive 40% Price Jump

Returns On Capital At Middle East Healthcare (TADAWUL:4009) Have Stalled

Feb 08
Returns On Capital At Middle East Healthcare (TADAWUL:4009) Have Stalled

Should You Be Adding Middle East Healthcare (TADAWUL:4009) To Your Watchlist Today?

Jan 18
Should You Be Adding Middle East Healthcare (TADAWUL:4009) To Your Watchlist Today?

Middle East Healthcare Company's (TADAWUL:4009) Revenues Are Not Doing Enough For Some Investors

Dec 28
Middle East Healthcare Company's (TADAWUL:4009) Revenues Are Not Doing Enough For Some Investors

Middle East Healthcare (TADAWUL:4009) Will Want To Turn Around Its Return Trends

Sep 26
Middle East Healthcare (TADAWUL:4009) Will Want To Turn Around Its Return Trends

Some Investors May Be Worried About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Jun 28
Some Investors May Be Worried About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Investors Could Be Concerned With Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Mar 30
Investors Could Be Concerned With Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Capital Allocation Trends At Middle East Healthcare (TADAWUL:4009) Aren't Ideal

Sep 20
Capital Allocation Trends At Middle East Healthcare (TADAWUL:4009) Aren't Ideal

Calculating The Intrinsic Value Of Middle East Healthcare Company (TADAWUL:4009)

Jun 14
Calculating The Intrinsic Value Of Middle East Healthcare Company (TADAWUL:4009)

Returns On Capital At Middle East Healthcare (TADAWUL:4009) Paint A Concerning Picture

Apr 18
Returns On Capital At Middle East Healthcare (TADAWUL:4009) Paint A Concerning Picture

Here's What's Concerning About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Aug 10
Here's What's Concerning About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Middle East Healthcare (TADAWUL:4009) Will Will Want To Turn Around Its Return Trends

Mar 29
Middle East Healthcare (TADAWUL:4009) Will Will Want To Turn Around Its Return Trends

An Intrinsic Calculation For Middle East Healthcare Company (TADAWUL:4009) Suggests It's 28% Undervalued

Mar 03
An Intrinsic Calculation For Middle East Healthcare Company (TADAWUL:4009) Suggests It's 28% Undervalued

Are Middle East Healthcare's (TADAWUL:4009) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 10
Are Middle East Healthcare's (TADAWUL:4009) Statutory Earnings A Good Guide To Its Underlying Profitability?

Weak Financial Prospects Seem To Be Dragging Down Middle East Healthcare Company (TADAWUL:4009) Stock

Jan 23
Weak Financial Prospects Seem To Be Dragging Down Middle East Healthcare Company (TADAWUL:4009) Stock

If You Had Bought Middle East Healthcare's (TADAWUL:4009) Shares Three Years Ago You Would Be Down 38%

Jan 05
If You Had Bought Middle East Healthcare's (TADAWUL:4009) Shares Three Years Ago You Would Be Down 38%

Should You Be Impressed By Middle East Healthcare's (TADAWUL:4009) Returns on Capital?

Dec 18
Should You Be Impressed By Middle East Healthcare's (TADAWUL:4009) Returns on Capital?

Calculating The Fair Value Of Middle East Healthcare Company (TADAWUL:4009)

Nov 30
Calculating The Fair Value Of Middle East Healthcare Company (TADAWUL:4009)

Stabilità e crescita dei pagamenti

Recupero dei dati sui dividendi

Dividendo stabile: Dati insufficienti per determinare se i dividendi per azione di 4009 siano rimasti stabili in passato.

Dividendo in crescita: Dati insufficienti per determinare se i pagamenti dei dividendi di 4009 siano aumentati.


Rendimento dei dividendi rispetto al mercato

Middle East Healthcare Rendimento dei dividendi rispetto al mercato
Come si colloca il rendimento da dividendo di 4009 rispetto al mercato?
SegmentoRendimento dei dividendi
Azienda (4009)0%
Fondo del 25% del mercato (SA)1.7%
Top 25% del mercato (SA)4.5%
Media del settore (Healthcare)1.4%
Previsione dell'analista in 3 anni (4009)1.3%

Dividendo notevole: Impossibile valutare il rendimento dei dividendi di 4009 rispetto al 25% inferiore dei pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.

Dividendo elevato: Impossibile valutare il rendimento dei dividendi di 4009 rispetto al 25% dei maggiori pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.


Distribuzione degli utili agli azionisti

Copertura degli utili: 4009 non sta pagando un dividendo degno di nota per il mercato SA.


Pagamenti in contanti agli azionisti

Copertura del flusso di cassa: Impossibile calcolare la sostenibilità dei dividendi poiché 4009 non ha segnalato alcun pagamento.


Scoprire le società che pagano dividendi forti